Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CRISABOROLE for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 125 adverse event reports in the FDA FAERS database where CRISABOROLE was used for Psoriasis.

Most Reported Side Effects for CRISABOROLE

Side Effect Reports % Deaths Hosp.
Drug ineffective 1,815 23.3% 1 6
Application site pain 1,414 18.2% 2 5
Burning sensation 975 12.5% 2 2
Off label use 673 8.7% 4 11
Condition aggravated 613 7.9% 2 12
Pain 468 6.0% 0 2
Pruritus 378 4.9% 2 4
Rash 342 4.4% 0 5
Eczema 308 4.0% 0 6
Erythema 285 3.7% 1 5
Product use in unapproved indication 242 3.1% 0 1
Application site erythema 234 3.0% 0 1
Drug hypersensitivity 234 3.0% 0 1
Drug ineffective for unapproved indication 230 3.0% 1 5
Skin burning sensation 214 2.8% 0 0

Other Indications for CRISABOROLE

Dermatitis atopic (2,139) Eczema (1,292) Dermatitis (407) Rash (220) Pruritus (123) Dermatitis contact (92) Dermatitis allergic (82) Seborrhoeic dermatitis (44) Erythema (42) Product used for unknown indication (38)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

CRISABOROLE Full Profile All Psoriasis Drugs CRISABOROLE Demographics CRISABOROLE Timeline